All lobbying filings
S-3 GROUP
S-3 GROUP filed a Q1 report for ORCHARD THERAPEUTICS NORTH AMERICA on April 17, 2026, reporting $60,000 in lobbying income.
Lobbying for ORCHARD THERAPEUTICS NORTH AMERICA · Biotech company
Filing · LD-2 quarterly report
Q1 report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 17, 2026
Income
$60,000
What the client paid this registrant for the period.
Client based in
Massachusetts
Lobbyists on this filing
5
-
MARTIN DELGADOPreviously held: Staff Dir, House Ag Approps, MilCon/VA Approps; Prof Staff, House Ag Approps, Senate Interior Approps; Budget Analysis, USDA APHIS
-
CHANDA BETOURNEYPreviously held: Dep. Staff Director and Chief Counsel, Senate Appropriations Cmt; Chief Counsel Civil Law and Oversight, Sen. Counsel, Sen. Judiciary Cmt; Leg Asst. and Projects Dir., Leg. Corresp., Senator Leahy
-
MARTIN REISERPreviously held: Policy Director, Republican Whip Steve Scalise, professional staff House Ways and Means Committee, Chief of Staff, Rep. Dan Miller, Budget Associate, House Budget Committee
-
CHRISTOPHER BUKIPreviously held: Staff Assistant/Legislative Correspondent, Representative John Culberson; Legislative Assistant/Senior Legislative Assistant, Representative Bill Shuster; Legislative Director/Deputy Chief of Staff, Representative David McKinley
-
MICHAELEEN EARLE CROWELLPreviously held: Leg Director, Rep. Denise Majette; Leg Director, Rep. John Lewis; Chief of Staff, US Sen. Bernie Sanders
Government bodies contacted
2
Lobbying activity
2
Issues related to funding for newborn screenings for metachromatic leukodystrophy
Issues related to funding for newborn screenings for metachromatic leukodystrophy